The IRIS™ Registry (Intelligent Research in Sight) is the world's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.
The IRIS™ Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence. It will provide for ophthalmologists:
- Easy-to-interpret benchmark reports that validate the quality care being provided and identify specific opportunities for improvement
- Access to clinically relevant data on diseases, including age-related macular degeneration, cataract and glaucoma
- Quality measurement solutions to help practices benefit from pay-for-performance incentives for which they may qualify
- Automated data collection – through electronic health record systems – that will fit seamlessly into practice workflow
Watch a recording of the Aug. 12 webinar “IRIS Registry: Improving Performance and Outcomes in Ophthalmology”.
Watch a recording of the Oct. 7 webinar “IRIS Registry: Streamline Your Quality Reporting and Realize Financial Benefits”.
Learn more about the benefits of participating.
The IRIS™ Registry has been developed by ophthalmologists, for ophthalmologists. It has been in the works for more than two years, under the direction of the Registry Measure Development Workgroup and with the input of subspecialty societies, state societies and many volunteers. Read the list of IRIS™ Registry development participants.
Academy CEO David W. Parke II, MD:
"We Didn't Become Physicians to be Average"
"Personally, I think we will all look back years from now and say this was one of the Academy's most important achievements," says Dr. Parke, in describing the launch of the IRIS™ Registry.
Watch his short introductory video to hear his perspectives on this dynamic technological initiative and its potential for improving patient care and practice efficiency.